Heartbeam Stock Today
BEAT Stock | USD 2.18 0.04 1.80% |
Performance0 of 100
| Odds Of DistressLess than 39
|
Heartbeam is selling for under 2.18 as of the 29th of March 2024; that is -1.8% down since the beginning of the trading day. The stock's last reported lowest price was 2.17. Heartbeam has about a 39 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. Equity ratings for Heartbeam are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 9th of May 2022 and ending today, the 29th of March 2024. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 11th of November 2021 | Category Healthcare | Classification Health Care |
HeartBeam, Inc., a medical technology company, primarily focuses on telemedicine solutions for the detection and monitoring of cardiac disease outside a healthcare facility setting. The company was incorporated in 2015 and is headquartered in Santa Clara, California. The company has 26.33 M outstanding shares of which 132.07 K shares are currently shorted by private and institutional investors with about 0.71 trading days to cover. More on Heartbeam
Moving against Heartbeam Stock
0.72 | MMSI | Merit Medical Systems Financial Report 24th of April 2024 | PairCorr |
0.57 | MBIO | Mustang Bio Report 3rd of April 2024 | PairCorr |
0.56 | CLVRW | Clever Leaves Holdings | PairCorr |
0.53 | LNSR | LENSAR Inc | PairCorr |
Follow Valuation Profit Patterns Odds of Bankruptcy
Financial Report 9th of May 2024
Heartbeam Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Heartbeam's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Heartbeam or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
CEO and President and Director | Joseph Capper | ||||
Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NASDAQ Composite, NASDAQ Composite Total, NASDAQ Health Care, Health Care, Health Care Equipment & Supplies, Health Information Services, Healthcare (View all Sectors) | ||||
Average Analyst Recommendation Analysts covering Heartbeam report their recommendations after researching Heartbeam's financial statements, talking to executives and customers, or listening in on Heartbeam's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Heartbeam. The Heartbeam consensus assessment is calculated by taking the average forecast from all of the analysts covering Heartbeam. | |||||
Heartbeam's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Heartbeam's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Heartbeam's financial leverage. It provides some insight into what part of Heartbeam's total assets is financed by creditors.
|
Heartbeam (BEAT) is traded on NASDAQ Exchange in USA. It is located in 2118 Walsh Avenue, Santa Clara, CA, United States, 95050 and employs 15 people. Heartbeam is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 57.4 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Heartbeam's market, we take the total number of its shares issued and multiply it by Heartbeam's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Heartbeam conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 26.33 M outstanding shares of which 132.07 K shares are currently shorted by private and institutional investors with about 0.71 trading days to cover.
Heartbeam currently holds about 9.27 M in cash with (12.09 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.16.
Check Heartbeam Probability Of Bankruptcy
Ownership AllocationHeartbeam secures a total of 26.33 Million outstanding shares. Heartbeam secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check Heartbeam Ownership Details
Heartbeam Stock Price Odds Analysis
Attributed to a normal probability distribution, the odds of Heartbeam jumping above the current price in 90 days from now is about 19.31%. The Heartbeam probability density function shows the probability of Heartbeam stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the stock has a beta coefficient of 2.3818 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Heartbeam will likely underperform. Additionally, heartbeam has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming NYSE Composite.
Based on a normal probability distribution, the odds of Heartbeam to move above the current price in 90 days from now is about 19.31 (This Heartbeam probability density function shows the probability of Heartbeam Stock to fall within a particular range of prices over 90 days) .
Heartbeam Stock Institutional Holders
Institutional Holdings refers to the ownership stake in Heartbeam that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Heartbeam's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Heartbeam's value.Instituion | Recorded On | Shares | |
Northern Trust Corp | 2023-12-31 | 47.3 K | |
Bakeravenue Asset Management, Lp | 2023-12-31 | 46.7 K | |
Spectrum Asset Management Inc | 2023-12-31 | 44.9 K | |
D'orazio & Associates Inc | 2023-12-31 | 33 K | |
Blackrock Inc | 2023-12-31 | 23.6 K | |
Harbour Investments, Inc. | 2023-12-31 | 19.8 K | |
Bank Of New York Mellon Corp | 2023-12-31 | 18.2 K | |
Charles Schwab Investment Management Inc | 2023-12-31 | 14.5 K | |
Ae Wealth Management Llc | 2023-12-31 | 13 K | |
Vanguard Group Inc | 2023-12-31 | 500.5 K | |
Geode Capital Management, Llc | 2023-12-31 | 200.4 K |
Heartbeam Historical Income Statement
Heartbeam Income Statement is one of the three primary financial statements used for reporting Heartbeam's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Heartbeam revenue and expense. Heartbeam Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Heartbeam's Gross Profit is comparatively stable compared to the past year. Cost Of Revenue is likely to gain to about 199 M in 2024, whereas Other Operating Expenses is likely to drop slightly above 14.5 M in 2024. View More FundamentalsHeartbeam Stock Against Markets
Picking the right benchmark for Heartbeam stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Heartbeam stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Heartbeam is critical whether you are bullish or bearish towards Heartbeam at a given time. Please also check how Heartbeam's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Heartbeam without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Premium Stories Now
Premium StoriesFollow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |
All Next | Launch Module |
Heartbeam Corporate Directors
Heartbeam corporate directors refer to members of a Heartbeam board of directors. The board of directors generally takes responsibility for the Heartbeam's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Heartbeam's board members must vote for the resolution. The Heartbeam board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.Joseph Frick | Independent Director | Profile | |
Laura Dietch | Director | Profile | |
Rebecca Rimel | Independent Director | Profile | |
Stephan Rietiker | Director | Profile |
How to buy Heartbeam Stock?
Before investing in Heartbeam, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Heartbeam. To buy Heartbeam stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Heartbeam. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Heartbeam stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Heartbeam stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Heartbeam stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Heartbeam, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Heartbeam Stock please use our How to Invest in Heartbeam guide.
Already Invested in Heartbeam?
The danger of trading Heartbeam is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Heartbeam is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Heartbeam. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Heartbeam is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Heartbeam is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Heartbeam Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Heartbeam Stock. Highlighted below are key reports to facilitate an investment decision about Heartbeam Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Heartbeam. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. For more information on how to buy Heartbeam Stock please use our How to Invest in Heartbeam guide.Note that the Heartbeam information on this page should be used as a complementary analysis to other Heartbeam's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Complementary Tools for Heartbeam Stock analysis
When running Heartbeam's price analysis, check to measure Heartbeam's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heartbeam is operating at the current time. Most of Heartbeam's value examination focuses on studying past and present price action to predict the probability of Heartbeam's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heartbeam's price. Additionally, you may evaluate how the addition of Heartbeam to your portfolios can decrease your overall portfolio volatility.
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |
Is Heartbeam's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Heartbeam. If investors know Heartbeam will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Heartbeam listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.72) | Return On Assets (0.90) | Return On Equity (1.60) |
The market value of Heartbeam is measured differently than its book value, which is the value of Heartbeam that is recorded on the company's balance sheet. Investors also form their own opinion of Heartbeam's value that differs from its market value or its book value, called intrinsic value, which is Heartbeam's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Heartbeam's market value can be influenced by many factors that don't directly affect Heartbeam's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Heartbeam's value and its price as these two are different measures arrived at by different means. Investors typically determine if Heartbeam is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Heartbeam's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.